Ovid Therapeutics Inc (OVID)
1.18
+0.06
(+5.36%)
USD |
NASDAQ |
Sep 27, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Cash from Investing (Quarterly): 12.82M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.82M |
| March 31, 2024 | 20.19M |
| December 31, 2023 | -48.52M |
| September 30, 2023 | -4.359M |
| June 30, 2023 | 20.07M |
| March 31, 2023 | 30.23M |
| December 31, 2022 | -4.170M |
| September 30, 2022 | -1.960M |
| June 30, 2022 | -80.68M |
| March 31, 2022 | -1.076M |
| December 31, 2021 | -0.162M |
| September 30, 2021 | -0.064M |
| June 30, 2021 | -1.584M |
| March 31, 2021 | -0.0115M |
| December 31, 2020 | -0.0905M |
| September 30, 2020 | -0.0383M |
| June 30, 2020 | 30.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.836M |
| December 31, 2019 | -35.01M |
| September 30, 2019 | -0.0186M |
| June 30, 2019 | 4.995M |
| March 31, 2019 | -0.009M |
| December 31, 2018 | 16.94M |
| September 30, 2018 | 17.91M |
| June 30, 2018 | 4.854M |
| March 31, 2018 | -45.07M |
| December 31, 2017 | 0.0617M |
| September 30, 2017 | -0.0253M |
| June 30, 2017 | -0.0312M |
| March 31, 2017 | -0.0526M |
| December 31, 2016 | -0.0881M |
| September 30, 2016 | -0.0654M |
| June 30, 2016 | -0.0073M |
| March 31, 2016 | -0.0282M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-80.68M
Minimum
Jun 2022
30.94M
Maximum
Jun 2020
-2.983M
Average
-0.0773M
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -2.199B |
| Tonix Pharmaceuticals Holding Corp | 0.00 |
| GlycoMimetics Inc | -0.0025M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.26M |
| Cash from Financing (Quarterly) | 0.356M |
| Free Cash Flow | -53.08M |
| Free Cash Flow Per Share (Quarterly) | -0.2023 |
| Free Cash Flow to Equity (Quarterly) | -14.40M |
| Free Cash Flow to Firm (Quarterly) | -14.40M |
| Free Cash Flow Yield | -63.53% |